Inspire Medical Systems Inc Total Liabilities
Inspire Medical Systems Inc total liabilities. Based on the latest financial reports, Inspire Medical Systems Inc (INSP) has total liabilities worth $100.41 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Inspire Medical Systems Inc (INSP) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Inspire Medical Systems Inc (2016–2025)
Total liabilities of Inspire Medical Systems Inc from 2016 to 2025. This chart illustrates how Inspire Medical Systems Inc's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Inspire Medical Systems Inc to see how much of total assets are deployed in long-term investments.
Inspire Medical Systems Inc Competitors by Total Liabilities
The table below lists competitors of Inspire Medical Systems Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ZhongAn Online P & C Insurance Co. Ltd
F:1ZO
|
Germany | €21.26 Billion |
|
Aarti Industries Limited
NSE:AARTIIND
|
India | Rs73.44 Billion |
|
Gas Malaysia Bhd
KLSE:5209
|
Malaysia | RM2.13 Billion |
|
Graubuendner Kantonalbank
SW:GRKP
|
Switzerland | CHF33.30 Billion |
|
Jointo Energy Investment Co Ltd Hebei
SHE:000600
|
China | CN¥27.65 Billion |
|
Genting Malaysia Bhd
KLSE:4715
|
Malaysia | RM19.44 Billion |
|
H2O America
NASDAQ:HTO
|
USA | $2.06 Billion |
|
Xizi Clean Energy Equipment Manufacturing Co Ltd
SHE:002534
|
China | CN¥8.40 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Inspire Medical Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Inspire Medical Systems Inc.
Liquidity & Leverage Metrics
Inspire Medical Systems Inc Total Liabilities Ratios Explained
Inspire Medical Systems Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inspire Medical Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual total liabilities of Inspire Medical Systems Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $126.16 Million | +6.29% |
| 2024-12-31 | $118.69 Million | +13.80% |
| 2023-12-31 | $104.30 Million | +51.44% |
| 2022-12-31 | $68.87 Million | +4.29% |
| 2021-12-31 | $66.04 Million | +28.37% |
| 2020-12-31 | $51.44 Million | +24.20% |
| 2019-12-31 | $41.42 Million | +14.79% |
| 2018-12-31 | $36.08 Million | +52.84% |
| 2017-12-31 | $23.61 Million | +19.69% |
| 2016-12-31 | $19.72 Million | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more